Fluid management strategies in heart failure

Critical Care Nurse

Volumn 32, Issue 2, 2012, Pages 20-32

  Albert, Nancy M ^a,b  

^a Nursing Institute   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FLUID THERAPY; HEART FAILURE; HUMAN; METHODOLOGY; NURSING; NURSING ASSESSMENT; NURSING METHODOLOGY RESEARCH; PATHOPHYSIOLOGY; PHYSIOLOGY; PLASMA VOLUME;

FLUID THERAPY; HEART FAILURE; HUMANS; NURSING ASSESSMENT; NURSING METHODOLOGY RESEARCH; PLASMA VOLUME;

EID: 84861165601     PISSN: 02795442     EISSN: None     Source Type: Journal    
DOI: 10.4037/ccn2012877     Document Type: Article

References (73)

1. Jessup M, Abraham WT, Casey DE, et al; 2009 Writing Group to Review New Evidence and Update the 2005 Guideline for the Management of Patients with Chronic Heart Failure Writing on Behalf of the 2005 Heart Failure Writing Committee. 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation. 2009; 119(14):1977-2016.
2. Metra M, Dei Cas L, Bristow MR. The pathophysiology of acute heart failure-it is a lot about fluid accumulation. Am Heart J. 2008; 155:1-5.
3. Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006;119(12 suppl 1):S3-S10.
4. Chen HH, Schrier RW. Pathophysiology of volume overload in acute heart failure syndromes. Am J Med. 2006;119(12 suppl 1): S11-S16.
5. Adams KF Jr, Fonarow GC, Emerman CL, et al; ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-216.
6. Gheorghiade M, Abraham WT, Albert NM, et al; OPTIMIZE-HF Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296:2217-2226.
7. Schrier RW. Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med. 1990;113(2):155-159.
8. Sarraf M, Masoumi A, Schrier RW. Cardiorenal syndrome in acute decompensated heart failure. Clin J Am Soc Nephrol. 2009;4: 2013-2026.
9. Cotter G, Felker M, Adams KF, Milo-Cotter O, O'Connor CM. The pathophysiology of acute heart failure-is it all about fluid accumulation? Am Heart J. 2008;155(1):9-18.
10. Cadnapaphornchai MA, Gurevich AK, Weinberger HD, Schrier RW. Pathophysiology of sodium and water retention in heart failure. Cardiology. 2001;96:122-131.
11. Lucas C, Johnson W, Hamilton MA, et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J. 2000;140:840-847.
12. Sayers SL, Riegel B, Goldberg LR, Coyne JC, Samaha FF. Clinical exacerbations as a surrogate end point in heart failure research. Heart Lung. 2008;37:28-35.
13. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154:260-266.
14. Lee DS, Austin PC, Stukel TA, et al. "Dosedependent" impact of recurrent cardiac events on mortality in patients with heart failure. Am J Med. 2009;122:162-169.
15. Androne AS, Hryniewicz K, Hudaihed A, Mancini D, Lamanca J, Katz SD. Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol. 2004;93:1254-1259.
16. Mueller C, Frana B, Rodriguez D, Laule-Kilian K, Perruchoud AP. Emergency diagnosis of congestive heart failure: impact of signs and symptoms. Can J Cardiol. 2005; 21:921-924.
17. Albert NM, Trochelman K, Li J, Lin S. Heart failure signs and symptoms: are you asking the right questions? Am J Crit Care. 2010; 19(5):443-452.
18. Webel AR, Frazier SK, Moser DK, Lennie TA. Daily variability in dyspnea, edema and body weight in heart failure patients. Eur J Cardiovasc Nurs. 2007;6:60-65.
19. Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM. Patterns of weight change preceding hospitalization for heart failure. Circulation. 2007;116:1549-1554.
20. Blair JE, Khan S, Konstam MA, et al; for EVEREST Investigators. Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial. Eur Heart J. 2009;30:1666-1673.
21. Zhang J, Goode KM, Cuddihy PE, Cleland JG; TEN-HMS Investigators. Predicting hospitalization due to worsening heart failure using daily weight measurement: analysis of the Trans-European Network-Home-Care Management System (TEN-HMS) study. Eur J Heart Fail. 2009;11(4):420-427.
22. Mehta RH, Rogers JG, Hasselblad V, et al. Association of weight change with subsequent outcomes in patients hospitalized with acute decompensated heart failure. Am J Cardiol. 2009;103:76-81.
23. Mahdyoon H, Klein R, Eyler W, Lakier JB, Chakko SC, Gheorghiade M. Radiographic pulmonary congestion in end-stage congestive heart failure. Am J Cardiol. 1989;63: 625-627.
24. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:884-888.
25. Maisel AS, Krishnaswamy P, Nowak RM, et al; Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-167.
26. James KB, Troughton RW, Feldschuh J, Soltis D, Thomas D, Fouad-Tarazi F. Blood volume and brain natriuretic peptide in congestive heart failure: a pilot study. Am Heart J. 2005;150:984.e1-984.e6.
27. O'Neill JO, Bott-Silverman CE, McRae AT, et al. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am Heart J. 2005; 149:363-369.
28. Heart Failure Society of America, Lindenfeld J, Albert NM, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010;16(6):e1-e194.
29. Liang KV, Williams AW, Greene EL, Redfield MM. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med. 2008;36(1 suppl):S75-S88.
30. Wang DJ, Gottlieb SS. Diuretics: still the mainstay of treatment. Crit Care Med. 2008; 36(1 suppl):S89-S94.
31. Massie BM, O'Connor CM, Metra M, et al; PROTECT Investigators and Committees. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med. 2010;363:1419-1428.
32. O'Connor CM, Miller AB, Blair JE, et al; Efficacy of Vasopressin Antagonism in heart Failure Outcome Study with Tolvaptan (EVEREST) investigators. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J. 2010;159:841-849.
33. Mebazaa A, Nieminen MS, Packer M, et al; SURVIVE Investigators. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA. 2007;297:1883-1891.
34. Cuffe MS, Califf RM, Adams KF Jr, et al; Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287(12):1541-1547.
35. Klein L, Massie BM, Leimberger JD, et al; OPTIME-CHF Investigators. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail. 2008;1:25-33.
36. Ronco C, Ricci Z, Bellomo R, Bedogni F. Extracorporeal ultrafiltration for the treatment of overhydration and congestive heart failure. Cardiology. 2001;96:155-168.
37. Marenzi GC, Lauri G, Grazi M, et al, Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol. 2001;38:963-968.
38. Costanzo MR, Guglin ME, Saltzberg MT, et al; UNLOAD trial investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007; 49:675-683.
39. Liang KV, Hiniker AR, Williams AW, Karon BL, Greene EL, Redfield MM. Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center. J Card Fail. 2006;12(9):707-714.
40. Shin JT, Dec GW. Ultrafiltration should not replace diuretics for the initial treatment of acute decompensated heart failure. Circ Heart Fail. 2009;2:505-511.
41. Koelling TM, Johnson ML, Cody RJ, Aaronson KD. Discharge education improves clinical outcomes in patients with chronic heart failure. Circulation. 2005;111(5):179-185.
42. Caldwell MA, Peters KJ, Dracup KA. A simplified education program improves knowledge, self-care behavior, and disease severity in heart failure patients in rural settings. Am Heart J. 2005;150:983e7-983e12.
43. Anderson C, Deepak BV, Amoateng-Adjepong Y, Zarich S. Benefits of comprehensive inpatient education and discharge planning combined with outpatient support in elderly patients with congestive heart failure. Congest Heart Fail. 2005;11(6):315-321.
44. Blue L, Lang E, McMurray JJ, et al. Random -ised controlled trial of specialist nurse intervention in heart failure. BMJ. 2001;225:715-718.
45. Soran OZ, Pína IL, Lamas GA, et al. A randomized clinical trial of the clinical effects of enhanced heart failure monitoring using a computer-based telephonic monitoring system in older minorities and women. J Card Fail. 2008;14:711-717.
46. Naylor MD, Brooten DA, Campbell RL, Maislin G, McCauley KM, Schwartz JS. Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial. J Am Geriatr Soc. 2004;52:675-684.
47. Kasper EK, Gerstenblith G, Hefter G, et al. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol. 2002;39:471-480.
48. Klersy C, Di Silvestri A, Gabutti G, Regoli F, Auricchio A. A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol. 2009;54:1683-1694.
49. Ferrante D, Varini S, Macchia A, et al. Longterm results after a telephone intervention in chronic heart failure. J Am Coll Cardiol. 2010; 56:372-378.
50. Albert NM, Buchsbaum R, Li J. Randomized study of the effect of video education on heart failure healthcare utilization, symptoms, and self-care behaviors. Patient Educ Couns. 2007;69(1-3):129-139.
51. Artinian NT, Harden JK, Kronenberg MW, et al. Pilot study of a Web-based compliance monitoring device for patients with congestive heart failure. Heart Lung. 2003;32(4): 226-233.
52. Whellan DJ, Ousdigian KT, Al-Khatib SM, et al; PARTNERS study investigators. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol. 2010; 55(17):1803-1810.
53. Catanzariti D, Lunati M, Landolina M, et al; Italian Clinical Service Optivol-CRT group. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing Clin Electrophysiol. 2009;32(3):363-70.
54. Welsh JD, Heiser RM, Schooler MP, et al. Characteristics and treatment of patients with heart failure in the emergency department. J Emerg Nurs. 2002;28(2):126-131.
55. White MM, Howie-Esquivel J, Caldwell MA. Improving heart failure symptom recognition: a diary analysis. J Cardiovasc Nurs. 2010; 25(1):7-12.
56. Sheahan SL, Fields B. Sodium dietary restriction, knowledge, beliefs, and decisionmaking behavior of older females. J Am Acad Nurse Pract. 2008;20(4):217-224.
57. Rosland AM, Heisler M, Choi HJ, Silveira MJ, Piette JD. Family influences on selfmanagement among functionally independent adults with diabetes or heart failure: do family members hinder as much as they help? Chronic Illn. 2010;6(1):22-33.
58. Morgan AL, Masoudi FA, Havranek EP, et al; for the Cardiovascular Outcomes Research Consortium (CORC). Difficulty taking medications, depression, and health status in heart failure patients. J Card Fail. 2006;12(1): 54-60.
59. Heckman GA, Patterson CJ, Demers C, St Onge J, Turpie ID, McKelvie RS. Heart failure and cognitive impairment: challenges and opportunities. Clin Interv Aging. 2007; 2(2):209-218.
60. Evangelista LS, Rasmusson KD, Laramee AS, et al. Health literacy and the patient with heart failure-implications for patient care and research: a consensus statement of the Heart Failure Society of America. J Card Fail. 2010;16(1):9-16.
61. Remme WJ, McMurray JJ, Hobbs FD, et al; SHAPE study group. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. Eur Heart J. 2008; 29(14):1739-1752.
62. Jhanjee R, Templeton GA, Sattiraju S, et al. Relationship of paroxysmal atrial tachy -arrhythmias to volume overload: assessment by implanted transpulmonary impedance monitoring. Circ Arrhythm Electrophysiol. 2009;2(5):488-494.
63. Koide K, Yoshikawa T, Nagatomo Y, et al. Elevated troponin T on discharge predicts poor outcome of decompensated heart failure. Heart Vessels. 2010;25(3):217-222.
64. Khasawneh FA, Smalligan RD. Focused transthoracic echocardiography. Postgrad Med. 2010;122(3):230-237.
65. Culp BC, Mock JD, Chiles CD, Culp WC. The pocket echocardiograph: validation and feasibility. Echocardiography. 2010;27(7): 759-764. doi:10.1111/j.1540-8175.2009.01125.x.
66. Maines M, Catanzariti D, Cirrincione C, Valsecchi S, Comisso J, Vergara G. Intrathoracic impedance and pulmonary wedge pressure for the detection of heart failure deterioration. Europace. 2010;12(5):680-685.
67. Albert NM, Yancy CW, Liang L, et al. Use of aldosterone antagonists in heart failure. JAMA. 2009;302:1658-1665.
68. Horwich TB, Hernandez AF, Liang L, et al; Get With the Guidelines steering committee and hospitals. Weekend hospital admission and discharge for heart failure: association with quality of care and clinical outcomes. Am Heart J. 2009;158:451-458.
69. Fonarow GC, Abraham WT, Albert NM, et al; OPTIMIZE-HF investigators and hospitals. Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). Am J Cardiol. 2009;104:107-115.
70. Ambardekar AV, Fonarow GC, Dai D, et al; Get With The Guidelines steering committee and hospitals. Quality of care and inhospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program). Am J Cardiol. 2010;105:139-143.
71. Fonarow GC, Abraham WT, Albert NM, et al; OPTIMIZE-HF investigators and hospitals. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med. 2008;168(8):847-854.
72. Annema C, Luttik ML, Jaarsma T. Reasons for readmission in heart failure: perspectives of patients, caregivers, cardiologists, and heart failure nurses. Heart Lung. 2009; 38:427-434.
73. Klapholz M, Maurer M, Lowe AM, et al; New York Heart Failure Consortium. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol. 2004;43:1432-1438.